Somatic mutations are abundant in TERT gene promoters and occur in more than 50% of the patients with HCC, while the protein alterations caused by gene mutations are often observed in CTNNB1 genes and TP53. This evidence concerns the gene TP53 and hepatocellular carcinoma.